Clinical Practice Guideline for Immune Globulin Released on IHE.ca
The IHE is pleased to have supported the development of Criteria for the Clinical Use of Immune Globulin, a clinical practice guideline (Prairie Collaborative CPG), produced through the Prairie Collaborative Immune Globulin Utilization Management Framework project.
The Prairie Collaborative Immune Globulin (IG) Utilization Management Framework project is a joint initiative of the Alberta, Manitoba, and Saskatchewan Ministries of Health to establish criteria for immune globulin therapy to improve the quality, safety, and sustainability of their respective blood supply systems. The project involved multidisciplinary committees comprised of specialists from the three provinces, and was supported by a research team from the Ambassador Guideline Adaptation and Development Program at the Institute of Health Economics (IHE). The guideline is intended to be used by transfusion medicine professionals and clinicians treating patients with conditions that require intravenous, subcutaneous, or oral preparations of human immune globulin; and administrators assessing and reviewing clinically appropriate access and program management.
The Prairie Collaborative CPG as well as a full description of the methods used to develop this evidence-based guideline are available now at: www.ihe.ca/research-programs/hta/aagap/immune-globulin-guideline. For more information about the IHE’s Ambassador Guideline Adaptation and Development Program, please visit: www.ihe.ca/research-programs/hta/aagap.
The IHE is an independent, not-for-profit organization that conducts health economics research and health technology assessment. Visit us at www.ihe.ca to learn more.
Director of Communications, Institute of Health Economics
Office: (780) 401-1768 | Cell: (780) 966-4879